Page last updated: 2024-08-23

bezafibrate and Myalgia

bezafibrate has been researched along with Myalgia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashizume, H; Horiguchi, N; Hosonuma, K; Kakizaki, S; Kusano, M; Sato, K; Yamada, M; Yamazaki, Y; Yanagisawa, M1
Castellaneta, NM; Di Leo, A; Facciorusso, A; Licinio, R1
Hosonuma, K; Kusano, M; Sato, K; Yamada, M1

Trials

1 trial(s) available for bezafibrate and Myalgia

ArticleYear
A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.
    The American journal of gastroenterology, 2015, Volume: 110, Issue:3

    Topics: Alkaline Phosphatase; Bezafibrate; Cholagogues and Choleretics; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Myalgia; Prognosis; Renal Insufficiency; Survival Rate; Time; Treatment Outcome; Ursodeoxycholic Acid

2015

Other Studies

2 other study(ies) available for bezafibrate and Myalgia

ArticleYear
Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?
    The American journal of gastroenterology, 2015, Volume: 110, Issue:7

    Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid

2015
Response to Licinio et al.
    The American journal of gastroenterology, 2015, Volume: 110, Issue:7

    Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid

2015